These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5405291)

  • 1. [Late cutaneous porphyria with sclerodermic syndrome revealed by taking estrogens, barbiturates and estro-progestational hormones].
    Durepaire-Fischer R; Goudal H; Bolgert M
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(3):281-4. PubMed ID: 5405291
    [No Abstract]   [Full Text] [Related]  

  • 2. [Porphyria cutanea tarda after prolonged taking of oral contraceptives].
    Degos R; Touraine R; Kalis B; Delort J; Bonvalet D
    Ann Dermatol Syphiligr (Paris); 1969; 96(1):5-14. PubMed ID: 5367491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucose intolerance test in patients treated with estro-progestational drugs].
    Marazzini F; Schubert L
    Ann Ostet Ginecol Med Perinat; 1967 Nov; 89(11):742-52. PubMed ID: 5611519
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cholestatic jaundice due to an estro-progestative drug preceding cholestatic jaundice of pregnancy].
    Dumont M; Karo G; Chambonnet R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):466-7. PubMed ID: 5153247
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatic complications of oral contraceptives (intrahepatic cholostasis of hormonal origin)].
    Vachon A; Notter A; Tête R; Gauthier J; Bertrand JL
    Rev Lyon Med; 1969 Mar; 18(5):189-96. PubMed ID: 5397089
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe changes in the endometrium caused by prolonged action of an estro-progestational synergy administered orally].
    Marty G; Rey C
    Bull Fed Soc Gynecol Obstet Lang Fr; 1969; 21(5):538-40. PubMed ID: 5386405
    [No Abstract]   [Full Text] [Related]  

  • 7. A new progestogen-estrogen combination for gynecologic therapy and contraception.
    Linthorst G
    Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Steroid jaundice: clinical and histological tests with a literature review].
    Vanden Berghe J; De Groote J; Desmet V
    Tijdschr Gastroenterol; 1966; 9(4):405-33. PubMed ID: 5336252
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraception with a new combination of lynestrenol (1mg) and mestranol (0,1mg).
    Panka J
    Ann Chir Gynaecol Fenn; 1969; 58(1):73-5. PubMed ID: 5367300
    [No Abstract]   [Full Text] [Related]  

  • 10. [Apropos of the appearance of chloasma during treatment with synthetic progestational agents].
    Rivoire J
    Lyon Med; 1967 Mar; 217(13):954-5. PubMed ID: 6042243
    [No Abstract]   [Full Text] [Related]  

  • 11. A new oral contraceptive with a 7 plus 15 sequential formulation.
    Brosens I; Van Assche A; Wijnants P
    Arzneimittelforschung; 1970 Feb; 20(2):236-7. PubMed ID: 5467468
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atypical organ-oriented effects of so-called ovulation inhibitors following bilateral nephrectomy, as well as unusual endometrial changes during long-term acyclinc therapy for chronicmyelosis].
    Schmid KO; Dapunt O
    Z Geburtshilfe Gynakol; 1968 Jun; 168(3):268-86. PubMed ID: 5678657
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endocervical polypoid hyperplasia in 2 women taking oral contraceptives].
    Rouchy R; Grosieux P
    Bull Fed Soc Gynecol Obstet Lang Fr; 1969; 21(1):72-3. PubMed ID: 5383887
    [No Abstract]   [Full Text] [Related]  

  • 14. [Porphyria cutanea tarda caused by long-term use of femigen].
    Chowaniec O; Wierzbieta J
    Przegl Dermatol; 1980; 67(3):349-52. PubMed ID: 6159665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Jaundice caused by the pill].
    Borel GA; Picardi R; Schelling JH; Magnenat P
    Helv Med Acta Suppl; 1967 May; 47():109. PubMed ID: 5286287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phlebitis occurring on the 2nd day of taking an estroprogestative agent].
    Mesnard F
    Bull Fed Soc Gynecol Obstet Lang Fr; 1965; 17(4):410-1. PubMed ID: 5858385
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical test of a combination of lynestrenol and mestranol (Lyndiol) as an oral contraceptive].
    Rice-Wray E; Becerra C; Esquivel J; Maqueo M
    Laval Med; 1967 May; 38(5):515-25. PubMed ID: 5606160
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies on Ovostat--a combined oral contraceptive with a low dose of lynestrenol].
    Rice-Wray E; Cervantes A
    Geburtshilfe Frauenheilkd; 1974 May; 34(5):380-3. PubMed ID: 4603404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-pathological study of the effects of contraceptive treatment with mestranol-lynestrol by a sequential type method].
    Arrizabalaga Amarelo R; Rojas M; Corral Gallardo J
    Ginecol Obstet Mex; 1972 Apr; 31(186):419-32. PubMed ID: 5028610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polypous endocervical polyadenoma in a woman taking an oral contraceptive].
    Duparc J; Boyron P
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(1):41-2. PubMed ID: 5559508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.